Showing 3,141 - 3,160 results of 4,739 for search '"malignancy"', query time: 0.06s Refine Results
  1. 3141

    Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol by Dongying Wang, Chunhua Zhao, Li Fu, Yang Liu, Weiyang Zhang, Tianmin Xu

    Published 2019-01-01
    “…Cervical clear cell adenocarcinoma (CCAC) is a rare malignant tumor with independent biological behavior in the female reproductive system. …”
    Get full text
    Article
  2. 3142

    Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy by Xia Liu, Emily Shaw, Fusheng Si, Guangyong Peng, Yan Tao, Feiya Ma, David Bagley, Yuanqin Zhang

    Published 2022-10-01
    “…In addition, melanoma mouse tumor immunotherapy models were performed to explore the synergistical efficacy of antitumor immunity via prevention of tumor-specific T cell senescence combined with anti-programmed death-ligand 1 (anti-PD-L1) checkpoint blockade therapy.Results We report that both mouse malignant tumor cells and Treg cells can induce responder T cell senescence, similar as shown in human Treg and tumor cells. …”
    Get full text
    Article
  3. 3143

    Elevated miR-221-3p inhibits epithelial–mesenchymal transition and biochemical recurrence of prostate cancer via targeting KPNA2: an evidence-based and knowledge-guided strategy by Dingchao Li, Jingang Jian, Manhong Shi, Zihao Chen, Anguo Zhao, Xuedong Wei, Yuhua Huang, Yalan Chen, Jianquan Hou, Yuxin Lin

    Published 2025-01-01
    “…Conclusions miR-221-3p down-regulation was a risk factor for PCa BRFS, and its over-expression could inhibit the malignant phenotype and EMT of PCa cells by directly targeting KPNA2. …”
    Get full text
    Article
  4. 3144

    RNA m6A involves in regulation of oxidative stress and apoptosis may via NF-kB pathway in cadmium-induced lung cells by Nan Zhang, Jie Yang, Yuan Zhao, Wenhong Li, Bo Zhao, Rongxian Li, Zuoshun He, Shiyan Gu

    Published 2025-01-01
    “…In present study, our data demonstrated that prolonged treatment of 1 μmol/L CdSO4 for 40 passages in bronchial epithelial cells (Beas-2B cells) resulted in the development of a malignant phenotype, which manifested as boosted proliferation, migration and invasion capacity as well as apoptosis reduction. …”
    Get full text
    Article
  5. 3145

    Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance by Bogdan Batko, Slawomir Jeka, Piotr Wiland, Agnieszka Zielińska, Maria Stopińska-Polaszewska, Marcin Stajszczyk, Magdalena Kosydar-Piechna, Mary Jane Cadatal, Jose L. Rivas

    Published 2024-07-01
    “…MACE IRs were similar in North America and Poland, and numerically higher versus Other countries. IRs for malignancies (excluding NMSC) were numerically higher in North America versus Poland/Other countries with tofacitinib. …”
    Get full text
    Article
  6. 3146

    Longitudinal MRI evaluation of the efficacy of non-enhanced lung cancer brain metastases by Xian Zhang, Jun Yang, Hong Hu, Yong Wang, Zhenfeng Zhang, Jinhao lv, Junping Li

    Published 2025-01-01
    “…Abstract Brain metastases (BM) are the most prevalent intracranial malignancies. Approximately 30–40% of cancer patients develop BM at some stage of their illness, presenting with a high incidence and poor prognosis. …”
    Get full text
    Article
  7. 3147

    Rare and syndromic tumours in South African children: A novel report from Sub-Saharan Africa by Alessia Pisapia, Guy Shemesh, Derek Harrison

    Published 2025-01-01
    “…The 10 most common variants included: malignant peripheral nerve sheath tumours (N = 15, 8 %, OS=47 %), nasopharyngeal carcinoma (N = 14, 8 %, OS=64 %), malignant melanoma (N = 14, 8 %, OS=43 %), Ewings sarcoma (N = 13, 7 %, OS=54 %), clear cell sarcoma of the kidney (N = 9, 5 %, OS=67 %), hepatocellular carcinoma (N = 9, 5 %, OS=22 %), desmoplastic small round cell tumour (N = 7, 4 %, OS=57 %), synovial sarcoma (N = 7, 4 %, OS=71 %), undifferentiated sarcoma (N = 6, 3 %, OS=66 %), infantile fibrosarcoma (N = 6, 3 %, OS=66 %). …”
    Get full text
    Article
  8. 3148
  9. 3149
  10. 3150

    Controlled Resistant Hypertension Following A Successful Renal Artery Stenting: A Rare Case Report in A Developing Country by Fatihatul Firdaus Munita, Badai Bhatara Tiksnadi, Januar Wibawa Martha, Margareta Ginanti Ratna

    Published 2025-01-01
    “…We report a case of a patient with uncontrollable hypertension with frequent episodes of malignant hypertension, treated with renal artery stenting. …”
    Get full text
    Article
  11. 3151

    Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis by Amneet Bajwa, Qiuhong Zhao, Marcus Geer, Chenyu Lin, James Westholder, Joseph Maakaron, Monalisa Ghosh, David Frame, Ahmed Galal, Justin Tossey, Nausheen Ahmed, Evandro Bezerra, Nathan Denlinger, Marcos de Lima, Narendranath Epperla, Paolo Caimi, Timothy Voorhees

    Published 2025-01-01
    “…Abstract: Chimeric antigen receptor T-cell (CAR-T) therapies are effective in many hematologic malignancies; however, adverse events including cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) can affect a significant number of patients. …”
    Get full text
    Article
  12. 3152

    The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas by Pinelopi Argyriou, Panagiota Economopoulou, Sotirios Papageorgiou

    Published 2012-01-01
    “…These agents have shown promising results in the treatment of lymphoid malignancies. On the other hand, new ATP-competitive mTOR inhibitors that provoke a broader inhibition of mTOR activity are in early stages of clinical development. …”
    Get full text
    Article
  13. 3153

    Epidural Brain Metastases in a Patient with Early Onset Pancreatic Cancer: A Case Report and Literature Review by Aibek E. Mirrakhimov, Farah N. Khan

    Published 2012-01-01
    “…A 46-year-old Caucasian non-Jewish nonobese male with a history of PC diagnosed 3 months ago with metastases to the liver, omentum, malignant ascites, and a history of a pulmonary embolism was admitted to the hospital because of a new onset headache, nausea, and vomiting which started 2 days prior to the encounter. …”
    Get full text
    Article
  14. 3154

    A Study On The Histopathological Analysis Of Nasal Masses Among Patients Attending The Ent Department Of Pakistan Institute Of Medical Sciences, Islamabad by Malik Jawad Faisal, Muhammad Arshad, Moniba Zafar, Ahmed Hasan Ashfaq, Syed Fahd Shah

    Published 2024-06-01
    “…Results: The most numerous groups of changes were non-cancerous nasal growth; 55 cases (68.25%), then 25 cases (32.25%) of nasal tumours, 16 benign, and 9 malignant cases in cancerous tumours. Conclusion: Nasal obstruction and rhinorrhea are the most commonly encountered symptoms in our community, with simple inflammatory nasal polyps being the predominant histological pattern. …”
    Get full text
    Article
  15. 3155

    Case Report: Metastatic squamous cell carcinoma in the left atrium by Shuai Luo, Xiaoxue Tian, Ting Xu, Jinjing Wang

    Published 2025-01-01
    “…BackgroundMetastatic tumours are the most common malignant tumours affecting the heart. Cardiac metastatic tumour progression is rapid, with no specific treatments available, and the prognosis is typically poor. …”
    Get full text
    Article
  16. 3156

    Cord Blood-Derived Hematopoietic Stem/Progenitor Cells: Current Challenges in Engraftment, Infection, and Ex Vivo Expansion by Katsuhiro Kita, Jong O. Lee, Celeste C. Finnerty, David N. Herndon

    Published 2011-01-01
    “…However, morbidity and mortality rates associated with hematopoietic malignancies still remain relatively high, even after cord blood transplantation. …”
    Get full text
    Article
  17. 3157

    Post Varicella Necrotising Fasciitis Afflicting Upper Limb in Young Child: A Rare Case Report by Swarup Prabhu, Ayjaz Hussain, Tarun Gupta

    Published 2024-03-01
    “…Risk factors include immunosuppression, type 2 diabetes mellitus, chronic diseases like cirrhosis of liver and chronic kidney disease, malignancies, intravenous drug use, obesity, and age more than 60 years. …”
    Get full text
    Article
  18. 3158

    CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist? by Marie José Kersten, Maria Theresa Kuipers

    Published 2025-01-01
    “…CD19-directed chimeric antigen receptor (CAR) T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for patients with autoimmune diseases. …”
    Get full text
    Article
  19. 3159

    Clinical forms of 5 cases of circumcised penile cancer in immunocompetent subjects in Abidjan (Ivory Coast) by Evrard Kouame Yao, Abraham Hognou Yao, Donafologo Daouda Yeo, Tawakaltu Adebayo, Michel Tuo, Freddy Junior Zouan, Noel Coulibaly

    Published 2025-02-01
    “…Abstract Context Malignant tumours of the penis are rare. Their incidence varies around the world and increases with age. …”
    Get full text
    Article
  20. 3160

    Iron Deficiency Anaemia Caused by Nonspecific (Idiopathic) Small Bowel Ulceration: An Uncommon Presentation of an Uncommon Disease by Gabriele Capurso, Edith Lahner, Nadia Pallotta, Francesco Panzuto, Gianfranco Delle Fave, Bruno Annibale

    Published 2002-01-01
    “…Ulcers of the small bowel are rare, and in most cases are due to infections, inflammatory bowel diseases, malignancies or drugs. When none of these causes is recognized, they are classified as ‘nonspecific’ or idiopathic. …”
    Get full text
    Article